141 related articles for article (PubMed ID: 18234958)
1. Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation.
Kadenhe-Chiweshe A; Papa J; McCrudden KW; Frischer J; Bae JO; Huang J; Fisher J; Lefkowitch JH; Feirt N; Rudge J; Holash J; Yancopoulos GD; Kandel JJ; Yamashiro DJ
Mol Cancer Res; 2008 Jan; 6(1):1-9. PubMed ID: 18234958
[TBL] [Abstract][Full Text] [Related]
2. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
[TBL] [Abstract][Full Text] [Related]
3. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
McCrudden KW; Hopkins B; Frischer J; Novikov A; Huang J; Kadenhe A; New T; Yokoi A; Yamashiro DJ; Kandel JJ; Middlesworth W
J Pediatr Surg; 2003 Mar; 38(3):308-14; discussion 308-14. PubMed ID: 12632340
[TBL] [Abstract][Full Text] [Related]
4. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
Dadiani M; Seger D; Kreizman T; Badikhi D; Margalit R; Eilam R; Degani H
Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
[TBL] [Abstract][Full Text] [Related]
5. Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature.
Frischer JS; Huang J; Serur A; Kadenhe-Chiweshe A; McCrudden KW; O'Toole K; Holash J; Yancopoulos GD; Yamashiro DJ; Kandel JJ
Int J Oncol; 2004 Sep; 25(3):549-53. PubMed ID: 15289855
[TBL] [Abstract][Full Text] [Related]
6. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling.
Lee A; Frischer J; Serur A; Huang J; Bae JO; Kornfield ZN; Eljuga L; Shawber CJ; Feirt N; Mansukhani M; Stempak D; Baruchel S; Glade Bender J; Kandel JJ; Yamashiro DJ
Cancer Res; 2006 Apr; 66(8):4378-84. PubMed ID: 16618763
[TBL] [Abstract][Full Text] [Related]
8. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.
Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137
[TBL] [Abstract][Full Text] [Related]
9. Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus.
Wang L; Dittmer DP; Tomlinson CC; Fakhari FD; Damania B
Cancer Res; 2006 Apr; 66(7):3658-66. PubMed ID: 16585191
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition.
Dang DT; Chun SY; Burkitt K; Abe M; Chen S; Havre P; Mabjeesh NJ; Heath EI; Vogelzang NJ; Cruz-Correa M; Blayney DW; Ensminger WD; St Croix B; Dang NH; Dang LH
Cancer Res; 2008 Mar; 68(6):1872-80. PubMed ID: 18339868
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt.
Nishi J; Minamino T; Miyauchi H; Nojima A; Tateno K; Okada S; Orimo M; Moriya J; Fong GH; Sunagawa K; Shibuya M; Komuro I
Circ Res; 2008 Aug; 103(3):261-8. PubMed ID: 18583712
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity.
Kawamura H; Li X; Harper SJ; Bates DO; Claesson-Welsh L
Cancer Res; 2008 Jun; 68(12):4683-92. PubMed ID: 18559514
[TBL] [Abstract][Full Text] [Related]
13. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
14. Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells.
Caron C; Spring K; Laramée M; Chabot C; Cloutier M; Gu H; Royal I
Cell Signal; 2009 Jun; 21(6):943-53. PubMed ID: 19233262
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.
Dai J; Peng L; Fan K; Wang H; Wei R; Ji G; Cai J; Lu B; Li B; Zhang D; Kang Y; Tan M; Qian W; Guo Y
Oncogene; 2009 Sep; 28(38):3412-22. PubMed ID: 19597469
[TBL] [Abstract][Full Text] [Related]
16. Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension.
Xia L; Fu GS; Yang JX; Zhang FR; Wang XX
Cytotherapy; 2009; 11(4):492-502. PubMed ID: 19526390
[TBL] [Abstract][Full Text] [Related]
17. Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo.
Hsu SC; Ou CC; Chuang TC; Li JW; Lee YJ; Wang V; Liu JY; Chen CS; Lin SC; Kao MC
Cancer Lett; 2009 Aug; 281(1):108-16. PubMed ID: 19332363
[TBL] [Abstract][Full Text] [Related]
18. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
[TBL] [Abstract][Full Text] [Related]
19. Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.
Parthymou A; Lampropoulou E; Mikelis C; Drosou G; Papadimitriou E
Eur J Cell Biol; 2008 Jan; 87(1):17-29. PubMed ID: 17881084
[TBL] [Abstract][Full Text] [Related]
20. The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells.
Ge YL; Zhang X; Zhang JY; Hou L; Tian RH
Int Immunopharmacol; 2009 Apr; 9(4):389-95. PubMed ID: 19162240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]